Medicine and Dentistry
Biopsy Technique
100%
Histopathology
54%
Magnetic Resonance Imaging
54%
Bullous Keratopathy
48%
Antibody-Drug Conjugate
48%
Depatuxizumab Mafodotin
48%
Squamous Cell Carcinoma
43%
Metastatic Carcinoma
37%
Optic Nerve
36%
Meningioma
36%
Visual Impairment
36%
Dermis
36%
Orbit Implant
34%
Vitreous
32%
Capsule of Lens
32%
Diseases
31%
Orbital Inflammation
30%
Diplopia
28%
Foreign Body
27%
Fibrinogen
27%
Contact Lens
25%
Scintigraphy
24%
Final Diagnosis
24%
Lacrimal Sac
24%
Stenosis
24%
Nivolumab
24%
Nocardia
24%
Melanosis
24%
Nerve Sheath
24%
Necrobiotic Xanthogranuloma
24%
Granuloma
24%
Conjunctival Biopsy
24%
Panophthalmitis
24%
Platelet Lysate
24%
ANCA Associated Vasculitis
24%
Lichen Sclerosus
24%
Encephalocele
24%
Cataract
24%
Endophthalmitis
24%
Immunoglobulin G4
24%
Adipose Tissue
24%
Gene Rearrangement
24%
Stroma of Cornea
24%
Somatostatin Receptor
24%
Acanthamoeba
24%
Stroma
24%
Fasciitis
24%
Fovea Centralis
24%
Visual Acuity
24%
Pediatrics Patient
24%
Keyphrases
Orbital Mass
48%
Toxic Keratopathy
48%
Histological Characterization
48%
ABT-414
48%
Belantamab Mafodotin
48%
Clinical Characterization
48%
Keratopathy
48%
Microcysts
48%
Antibody-drug Conjugate
48%
Cornea
44%
Older Men
42%
Lens Capsule
34%
Left Eye
34%
Periorbital
32%
Recurring
32%
Dermis Fat Graft
31%
Orbital Inflammation
30%
Crystalline Lens
29%
Lenticular
29%
Squamous Cell Carcinoma (SqCC)
29%
Tumor
27%
Young Males
27%
Conjunctival
27%
Fibrinogen
27%
Orbital Implant Exposure
24%
Panophthalmitis
24%
USP6 Gene
24%
Nodular Fasciitis
24%
Perineuritis
24%
Nivolumab
24%
Ipilimumab
24%
Nocardia Endophthalmitis
24%
Giant Cell Tumor
24%
Optic Nerve Sheath
24%
Frontal Bone
24%
Delayed Onset
24%
Ectopic Meningioma
24%
Spheno-orbital Meningioma
24%
Somatostatin Receptor Scintigraphy
24%
Inflammatory Granuloma
24%
Diplopia
24%
Metastatic Breast Carcinoma
24%
Necrobiotic Xanthogranuloma
24%
Orbital Soft Tissue
24%
Punctal Stenosis
24%
Superior Oblique
24%
Implant Removal
24%
Intravenous Immunoglobulin (IVIg)
24%
Dry Eye
24%
Strabismus Surgery
24%